February marks progress in overturning terrible odds. The landscape has changed. Drug companies more and more recognize that rare diseases have provided some of the most important medical breakthroughs on record. The therapies they're funding are finding new and more applications.
At first -- okay, for a while -- I was angry. This was not the way I'd planned spending my formative years, after all. But then I began to contemplate making peace with my enemy, strange as that sounds.